3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
8
Prostatic Neoplasms, Castration-Resistant
1
Neoplasm Metastasis
1
Metastatic Castration-resistent Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Castration-resistant Prostate Cancer
1
Adenocarcinoma of the Prostate
1
Interventions
pembrolizumab
1
enzalutamide
1
abiraterone
1
Radium-223
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Castration-resistant Prostate Cancer
×
enzalutamide
×
Clear all
NCT03305224
2021-09-09
CORE-OCU
Osaka City University
Phase 2
Unknown
10 enrolled